Company / Income Tax
TG Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$339.8M
FY2025
5-year range
-$339.8M / $2.2M
FY2021-FY2025
Trend
-15468.1%
vs FY2024
Sector context
#204 of 204
Health Care
What the data says
Income Tax changed -15468% YoY in FY2025, a notable deviation from the 2-year average annual change of -7501%.
Based on SEC 10-K filings.
-$340M in FY2025.
Improved from $390,000 to -$340M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 204This company -$339.8M Sector average $118.7M
▼
-386.2% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 15468.1% year-over-year.
- Ranks #204 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$339.8M | -15468.1% |
| FY2024 | $2.2M | +466.9% |
| FY2023 | $390.0K | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026